About Eton Pharmaceutcials, Inc. Common Stock
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
Market Cap
$0.36B
Employees
31
Listed Since
November 14, 2018
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.etonpharma.comPhone
(847) 787-7361
Headquarters
21925 W. FIELD PARKWAY
DEER PARK, IL 60010-7278
CIK
0001710340
No content available for this security